“…Numerous studies have identified a number of single nucleotide polymorphisms that are associated with alcohol dependence and/or drug codependence including (a) CHRM2 (Luo et al, 2005; Wang et al, 2004), CHRNA4 (Kim et al, 2004), CHRNA5 (Saccone et al, 2007; Wang et al, 2009) as well as the CHRNA5-CHRNA3-CHRNB4 cluster and alcohol abuse/dependence (Schlaepfer et al, 2008); (b) DAT (Heinz, Goldman, Gallinat, Schumann, & Puls, 2004; see also Bhaskar & Kumar, 2014 for this and other DA-associated polymorphisms), DA beta hydroxylase (DBH) and alcohol dependence in women (Preuss et al, 2013), DRD3 and alcohol craving (Agrawal et al, 2013) as well as DA dysfunction and Cloninger Type I alcoholism (Leggio & Addolorato, 2008); (c) GABRA1, GABRA2, GABRB3, GABRG3 and alcohol dependence or sensitivity to its intoxicating effects during the ascending slope of the BAC curve (e.g., Bierut et al, 2010; Dick et al, 2004; Dick et al, 2006; Edenberg et al, 2004; Enoch, Schwartz, Albaugh, Virkkunen, & Goldman, 2006; Haughey et al, 2008; Noble et al, 1998); (d) GRIK3 (Grzywacz, Malecka, Suchanecka, Bienkowski, Samochowiec, 2013) and GRIN2A (Domart et al, 2012) with alcohol dependence as well as GRM8 and event-related potential (ERP) theta power and alcohol dependence (Chen et al, 2009); (e) 5HT dysfunction and Cloninger Type II alcoholism (Leggio & Addolorato, 2008), HTR1A and alcohol as well as nicotine co-dependence (Zuo et al, 2013), HTR1B and alcohol as well as multiple drug abuse (Cao, LaRocque, & Li, 2013; Contini et al, 2012), HTR2A and alcohol as well as heroin abuse (Cao et al, 2014), HTR7 and alcohol dependence as wel as electrophysiological measures (Zlojutro et al, 2010; Zuo et al, 2014), alcohol dependence and SERT (e.g., Heinz et al, 2004; c.f., Johnson, 2010; McHugh, Hofman, Asnaani, Sawyer, & Otto, 2010; Plemenitas et al, 2015); (f) OPRM1 and level of response to ethanol in Native Americans (Ehlers, Lind, & Wilhelmsen, 2008), OPRM1 polymorphisms and naltrexone’s efficacy for treating alcohol dependence (e.g., Jonas et al, 2014), as well as PDYN and OPRK1 with alcohol dependence (Gerra et al, 2007; Williams et al, 2007; Xuei et al, 2006); (g) CRFR1 polymorphism with P3 ERP and alcohol dependence (Chen et al, 2010); and (h) NPY and its receptor’s association with alcohol as well as multiple drug abuse and dependencies (Bhaskar et al, 2013; Frances et al, 2011; Okahisa et al, 2009; Sato et al, 2010; Wether...…”